Nice to see some new and familiar faces at our FBR investor lunch today!
Really good discussion, with Mark Pivac (CEO) doing a great job running through the FBR story and recent updates. Thanks to everyone who came along.
Across Markets…
The Australian sharemarket fell on Wednesday after inflation rose more than expected, strengthening the case for an interest rate increase by the Reserve Bank of Australia next week.
The S&P/ASX 200 Index fell 7.7 points, or 0.1 per cent, to 8933.90, reversing stronger gain earlier. The annual consumer price index rose to 3.8 per cent in December from 3.4 per cent in November, above market expectations of 3.6 per cent and the RBA’s forecast of 3.2 per cent for the December quarter.
Money markets lifted the probability of a rate rise to about 75 per cent, up from 61 per cent before the data, following a stronger-than-expected labour market report last week. The Australian dollar climbed to a three-year high of US70.22¢, supported by rate expectations and a weaker US dollar. Betashares chief economist David Bassanese said the inflation data showed underlying price pressures evident in the September quarter had persisted.
“The RBA seemingly has little choice but to throttle back current economic momentum through at least one, possibly two, rate hikes in the first half of this year,” he said. “All up, it appears to be Game, Set & Match for a rate rise at the February policy meeting.”
On the ASX, the rate sensitive sector tech sector weighed as WiseTech Global fell 3.8 per cent to $60.70, NextDC 2.7 per cent to $13.34 and Life360 by 7.6 per cent to $28.52 as investor also looked to profit take the latter after a 27 per cent bounce last Friday.
The major banks were mixed as ANZ lost 0.5 per cent to $36.40, Westpac 0.2 per cent to $38.87, National Australia Bank flat at $42.87 and Commonwealth Bank rose 0.2 per cent to $150.36.
Energy though gained on higher oil prices as a US winter storm disrupted crude production and refinery operations. Woodside rose 2.7 per cent to $24.98 as record production beat guidance, while Santos firmed 3 per cent to $6.82.
Materials were buoyed as gold rose above $US5200 to a record high, fuelled by US dollar weakness and a flight from sovereign bonds and currencies. Northern Star advanced 3.3 per cent to $28.60, Evolution Mining 4 per cent to $15.35 and Perseus 2.2 per cent to $6.43. Broader commodities pushed BHP up 1.7 per cent to $50.60.
Source: AFR
Eden Innovations Strengthens Balance Sheet as EdenCrete And OptiBlend Sales Momentum Builds
Eden Innovations (ASX: EDE) has reported continued commercial progress across its EdenCrete and OptiBlend product lines, alongside the near-completion of a major balance sheet restructure during the December 2025 quarter.
The company completed a $4.35 million equity raising and materially reduced its debt burden, leaving it better positioned to support sales growth and operational execution.
Eden has reduced total debt by approximately $16m since 30 June 2025 through asset sales, refinancing, and the conversion of shareholder loans.
The company said the strengthened financial position supports its objective of reaching positive cash flow during calendar year 2026.
EdenCrete Sales And Project Activity
Eden reported its third and largest EdenCrete Pz7 order from Holcim Ecuador during the quarter—a US$341,850 order despatched in December and delivered in January.
Holcim has purchased more than $1m of EdenCrete Pz7 since February 2024, with Eden estimating annual sales to the customer could grow to around US$800,000.
EdenCrete Pz7 continued to be specified on major infrastructure and commercial projects in the US, including the Bellview Station Block F development in Denver and the Colorado Department of Transportation I-70 Floyd Hill expansion.
Eden said contractors on these projects have reported consistently strong concrete performance, with enhanced compressive strength and durability attributed to Pz7.
The company also continued EdenCrete Pz7 trials in India with the Central Road Research Institute, targeting highway, bridge, and pavement applications across large-scale infrastructure markets.
OptiBlend Commercial Momentum
OptiBlend sales accelerated in the US during the quarter, driven by growing demand from data centres and industrial customers seeking fuel efficiency and emissions performance.
Eden received nine OptiBlend orders worth US$455,000 during the first four months of FY26, with total US OptiBlend orders in October alone accounting for around 80 per cent of full-year FY25 sales.
OptiBlend revenue received during the quarter totalled US$265,380, with purchase orders awaiting delivery and installation valued at approximately US$674,000 as at 31 December.
Eden US had live OptiBlend quotations issued totalling more than US$4.1m at quarter end, reflecting an expanding pipeline of prospective sales.
The company is also pursuing OptiBlend opportunities across India, Africa, and the Middle East through a combination of direct sales and regional representatives.
Financial Reconstruction
Eden completed the placement of shortfall shares from its entitlement offer during the quarter, raising $4.35m before costs, including $250,000 from major shareholder Noble Energy.
The company used the proceeds to further reduce its high-interest debt, including the repayment and extinguishment of the remaining iBorrow loan balance.
Subsequent to quarter end, Eden secured a $2.2m strategic convertible note investment from a major shareholder, removing remaining quarterly debt servicing obligations.
As at 31 December 2025, Eden held cash and cash equivalents of $3.67m, equating to an estimated funding runway of approximately 2.7 quarters based on recent operating cash outflows.
Improved Operating Leverage
The combination of recurring EdenCrete orders, expanding OptiBlend demand and a materially strengthened balance sheet positions Eden for improved operating leverage.
The company’s focus remains on converting trial programs into repeat commercial sales while maintaining disciplined cost control.
Eden will continue to prioritise markets where durability, sustainability, and performance advantages translate into repeat customer adoption.
The board said the financial reconstruction substantially de-risks the business as it works toward sustained cash flow generation.
Source: SmallCaps
Company: Fin Resources Ltd (ASX:FIN)
Sector: Gold/Mining
Deal Type: Placement
Latest Entry Price: $0.0065
Today’s Price Change: $0.014 Unchanged
Company: Locksley Resources Ltd (ASX:LKY)
Sector: REE & Antimony/Mining
Deal Type: Placement
Latest Entry Price: $0.04
Today’s Price Change: $0.190 -2.56%
Company: CuFe Ltd (ASX:CUF)
Sector: Copper/Mining
Deal Type: Placement
Latest Entry Price: $0.016 with 1:2 option, strike $0.025
Today’s Price Change: $0.046 +4.55%
Company: Tasman Resources Ltd (ASX:TAS)
Sector: Gold/Silver/Mining
Deal Type: Placement
Latest Entry Price: $0.0125 with 1:2 option, strike $0.02
Today’s Price Change: $0.047 +9.3%
Company: Tambourah Metals Ltd (ASX:TMB)
Sector: Gold/Mining
Deal Type: Placement
Latest Entry Price: $0.04
Today’s Price Change: $0.058 Unchanged
Company: Biotron Ltd (ASX:BIT)
Sector: Biotech
Deal Type: Placement
Latest Entry Price: $0.003 with 1:2 option, strike $0.02
Today’s Price Change: $0.004 +33.33%
Company: Eclipse Metals Ltd (ASX:EPM)
Sector: REE
Deal Type: Placement
Latest Entry Price: $0.015
Today’s Price Change: $0.026 Unchanged
Company: Neuren Pharmaceuticals Ltd (ASX:NEU)
Sector: Biotech
Deal Type: On-market purchase
Latest Entry Price: $1.20 – $1.50
Today’s Price Change: $17.10 -1.89%
Company: Dimerix Ltd (ASX:DXB)
Sector: Biotech
Deal Type: Rights Issue
Raise Amount: $800,000
Latest Entry Price: $0.08 with 1:1 option, strike $0.126
Today’s Price Change: $0.525 Unchanged
Sector: Blockchain
Deal Type: Placement
Raise Amount: $1M
Latest Entry Price: $0.02 with 1:1 option $0.08 strike
Today’s Price Change: $0.029 +26.09%
Company: Critica Limited (ASX:CRI)
Sector: REE
Deal Type: Placement
Raise Amount: $1M
Latest Entry Price: $0.0075 with a 1:1 CRIO
Today’s Price Change: $0.034 +41.67%
Sector: Lithium
Deal Type: IPO
Raise Amount: $8.6M
Latest Entry Price: $0.09 with 1:2 PL3O
Today’s Price Change: $0.11 Unchanged
Sector: Cybersecurity & AI
Deal Type: Placement
Raise Amount: $1.7M
Latest Entry Price: $0.01 with 1:3 option $0.02 strike
Today’s Price Change: $0.008 Unchanged
Sector: Gold/Mining
Deal Type: Placement
Raise Amount: $2.3M
Latest Entry Price: $0.026 with 1:2 option $0.032 strike
Today’s Price Change: $0.049 +2.08%
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak accepts no responsibility for any views expressed and marketing material contained in this email except where the message specifically states otherwise and the sender is authorised to state them to be the views of Peak. Information provided in this email is general advise only and does take account your objectives, financial situation or needs. Before acting on any advice in this email, Peak recommends that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, you should obtain the current Product Disclosure Statement (PDS) or other disclosure documents for the particular products and consider this information before making any decisions regarding the products. The Financial Services Guide (FSG) can be found at www.peakassetmanagement.com.au or by telephoning Peak on 1300 304 460
Comments are closed